What is NCT04502433 (and how does it relate to poractant alfa)?
NCT04502433 is a clinical trial listing on CenterWatch that includes poractant alfa among its studied therapies. Poractant alfa is a type of pulmonary surfactant used in neonatal care, typically for respiratory distress syndrome in premature infants.
How can you check the “status” on CenterWatch for NCT04502433?
On CenterWatch, the “status” field for a trial typically reflects where the study sits in its lifecycle (for example, recruiting, active/not recruiting, completed, or withdrawn). To confirm the exact current status for NCT04502433, open the CenterWatch page for NCT04502433 and read the trial’s Status line directly.
Is poractant alfa tied to this trial’s recruitment or results?
CenterWatch trial status usually indicates recruitment and ongoing activity for the entire study protocol, not just one drug arm. For NCT04502433, the poractant alfa involvement would appear in the trial’s interventions/arms section, while the status line tells you whether participants are currently being enrolled, whether follow-up is underway, or whether the study has finished.
If you want, I can verify the exact status text
If you paste the CenterWatch page text for “Status” (or share the link to the NCT04502433 page), I can interpret it and tell you what it means in practice (e.g., whether you can still enroll, whether it’s ended, and what that implies for timelines).